Luncheon Meeting with Management to be held in San Francisco on January 12 hosted by Oppenheimer.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX:
- Immuneering to announce OS data from Phase 2a trial of atebimetinib, mGnP
- Immuneering on track to dose first patient in pancreatic cancer trial in 2026
- Immuneering to be added to the Nasdaq Biotechnology Index
- Immuneering Corp. Shines in Positive Earnings Call
- Promising Potential of Immuneering’s Atebimetinib: Analyst Recommends ‘Buy’ Rating